321 related articles for article (PubMed ID: 27676086)
1. Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy.
Wu J; Lin Y; Li H; Jin Q; Ji J
J Colloid Interface Sci; 2017 Jan; 485():251-259. PubMed ID: 27676086
[TBL] [Abstract][Full Text] [Related]
2. Design and Proof of Programmed 5-Aminolevulinic Acid Prodrug Nanocarriers for Targeted Photodynamic Cancer Therapy.
Wu J; Han H; Jin Q; Li Z; Li H; Ji J
ACS Appl Mater Interfaces; 2017 May; 9(17):14596-14605. PubMed ID: 28397487
[TBL] [Abstract][Full Text] [Related]
3. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
4. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
5. Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.
Johnson RP; Chung CW; Jeong YI; Kang DH; Suh H; Kim I
Int J Nanomedicine; 2012; 7():2497-512. PubMed ID: 22679363
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL
Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502
[TBL] [Abstract][Full Text] [Related]
7. Activity of phosphatase-sensitive 5-aminolevulinic acid prodrugs in cancer cell lines.
Herceg V; Lange N; Allémann E; Babič A
J Photochem Photobiol B; 2017 Jun; 171():34-42. PubMed ID: 28472723
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates.
Zhang J; Yuan S; Fan M; Wang K; Guo J; Zang A; Ren J; Su W; Zhang C; Xie Y
Bioorg Med Chem; 2024 May; 105():117726. PubMed ID: 38626642
[TBL] [Abstract][Full Text] [Related]
9. [5-Aminolevulinic acid esters based photodynamic therapy].
Zhang S; Zhang Z; Jiang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308
[TBL] [Abstract][Full Text] [Related]
10. Cooperative effect of 5-aminolevulinic acid and gold nanoparticles for photodynamic therapy of cancer.
Benito M; Martín V; Blanco MD; Teijón JM; Gómez C
J Pharm Sci; 2013 Aug; 102(8):2760-9. PubMed ID: 23712859
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic acid-loaded fullerene nanoparticles for in vitro and in vivo photodynamic therapy.
Li Z; Pan LL; Zhang FL; Zhu XL; Liu Y; Zhang ZZ
Photochem Photobiol; 2014; 90(5):1144-9. PubMed ID: 24913433
[TBL] [Abstract][Full Text] [Related]
12. Enhancing selective photosensitizer accumulation and oxygen supply for high-efficacy photodynamic therapy toward glioma by 5-aminolevulinic acid loaded nanoplatform.
Wang X; Tian Y; Liao X; Tang Y; Ni Q; Sun J; Zhao Y; Zhang J; Teng Z; Lu G
J Colloid Interface Sci; 2020 Apr; 565():483-493. PubMed ID: 31982715
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy.
Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
Mol Cancer Ther; 2008 Jun; 7(6):1720-9. PubMed ID: 18566243
[TBL] [Abstract][Full Text] [Related]
14. Dual pH-responsive 5-aminolevulinic acid pseudopolyrotaxane prodrug micelles for enhanced photodynamic therapy.
Tong H; Wang Y; Li H; Jin Q; Ji J
Chem Commun (Camb); 2016 Mar; 52(20):3966-9. PubMed ID: 26882232
[TBL] [Abstract][Full Text] [Related]
15. Immobilization of ALA-Zn(II) Coordination Polymer Pro-photosensitizers on Magnetite Colloidal Supraparticles for Target Photodynamic Therapy of Bladder Cancer.
Tan J; Sun C; Xu K; Wang C; Guo J
Small; 2015 Dec; 11(47):6338-46. PubMed ID: 26514273
[TBL] [Abstract][Full Text] [Related]
16. Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug.
Feuerstein T; Berkovitch-Luria G; Nudelman A; Rephaeli A; Malik Z
Photochem Photobiol Sci; 2011 Dec; 10(12):1926-33. PubMed ID: 22020364
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel Schiff base derivative for enhancing the anticancer potential of 5-aminolevulinic acid-based photodynamic therapy.
Shinohara Y; Endo Y; Abe C; Shiba I; Ishizuka M; Tanaka T; Yonemura Y; Ogura SI; Tominaga M; Yamada H; Uto Y
Photodiagnosis Photodyn Ther; 2017 Dec; 20():182-188. PubMed ID: 29056554
[TBL] [Abstract][Full Text] [Related]
18. Glycoside esters of 5-aminolevulinic acid for photodynamic therapy of cancer.
Vallinayagam R; Schmitt F; Barge J; Wagnieres G; Wenger V; Neier R; Juillerat-Jeanneret L
Bioconjug Chem; 2008 Apr; 19(4):821-39. PubMed ID: 18341270
[TBL] [Abstract][Full Text] [Related]
19. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S; Olsen J; Howley R; Chen B
Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of X-ray treatment and photodynamic therapy by using 5-aminolevulinic acid conjugated gold nanoparticles in a melanoma cell line.
Mohammadi Z; Sazgarnia A; Rajabi O; Seilanian Toosi M
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):467-473. PubMed ID: 27052440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
